FDA-Registered Manufacturing

BOSTON, Massachusetts, June 30, 2026 Skyhawk Therapeutics has announced encouraging 12-month interim results from its ongoing Phase 1/2 clinical...

SUZHOU, China, and MÖLNDAL, Sweden, July 2, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...

FORT MYERS, Florida, July 2, 2026 Trilogy Laboratories has announced the acquisition of YNS Cosmeceuticals, a respected skincare brand...